VANCOUVER, BC, Aug. 17, 2021 /PRNewswire/ -- The global 3D bioprinting market size is expected to reach USD 2,687.8 Million in 2027 at a CAGR of 20.7% during the forecast period, according to the recent report by Emergen Research. Rapid technological advancements in 3D bioprinters, increasing investment to accelerate research and development activities of bioprinters, and rising use of 3D bioprinters to develop biomaterials for drug research and regeneration of joints and ligaments are key factors expected to drive market revenue growth over the forecast period. In addition, numerous advantages of 3D bioprinting in organ reconstruction to treat various end-stage disorders is another key factor contributing to the revenue growth of the market.

3D bioprinting leverages techniques similar to additive manufacturing to mix up growth factors, cells, and biomaterials to create biomedical parts that can mimic natural tissue attributes. 3D bioprinting leverages layer-by-layer technique to add materials called as bioinks to create tissue-like structures that can be used in medical and tissue engineering procedures. Recent advancements in the technique has expanded its scope in drug design and development by creating target tissues and cells for drug research and testing. In addition, 3D bioprinters can be used to reconstruct tissues from any body part and this has further increased its applications for treating various severe and chronic disorders. Significant progress in tissue engineering and production of biomaterials have contributed considerably to the 3D bioprinting market growth.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@https://www.emergenresearch.com/request-sample/133

3D bioprinters have been extensively used in vaccine research during the COVID-19 pandemic. Bioprinting is widely being used in the development of regenerative medicines, stem cell therapies, drug research and therapies, and tissue and organ reconstruction. Increasing application of 3D bioprinting in cosmetic and pharmaceutical sector is also a key factor contributing to the revenue growth of the market going ahead. However, lack of skilled professionals and technical knowledge, high costs of 3D bioprinting, and limited access to advanced technologies in developing and underdeveloped countries are some key factors expected to restrain market growth to a significant extent over the forecast period.

Some Key Highlights in the Report:

Buy your Exclusive copy [Make Payment ]@ https://www.emergenresearch.com/select-license/133

For the purpose of this report, Emergen Research has segmented the global 3D bioprinting market on the basis of technology, material, application, and region:

Technology Outlook (Revenue, USD Million; 2017-2027)

Material Outlook (Revenue, USD Million; 2017-2027)

Application Outlook (Revenue, USD Million; 2017-2027)

Have a look at Report Description and Table of Contents of Market Research [emailprotected] https://www.emergenresearch.com/industry-report/3d-bioprinting-market

Regional Outlook (Revenue, USD Million; 2017-2027)

Explore more reports offered by Emergen Research:

The Global Oncology Informatics Market size was valued at USD 4.62 Billion in 2019 and is anticipated to reach USD 8.01 Billion by 2027 at a CAGR of 7.1%. An increase in the awareness of the different types of treatment options for oncology will drive the demand for the oncology informatics market. The major driving factor is the rise in the prevalence of cancer and heavy investment by the government institutes and research organizations.

The Global Nerve Repair and Regeneration Market size was valued at USD 6.05 Billion in 2019 and is forecasted to reach USD 11.62 Billion by 2027 at a CAGR of 9.0%. The market is mainly driven by the rising geriatric population and the increasing prevalence of nerve injuries. The high incidence of neurological disorders among the growing population is expected to drive the Nerve Repair and Regeneration Market growth.

The Global Spinal Fusion Devices Market size was valued at USD 6.88 Billion in 2019 and is forecasted to reach USD 8.90 Billion by 2027 at a CAGR of 3.5%. The market is mainly driven by the increasing aging population and their growing need for spine care. Advancements in surgical technology is a key contributing factor behind the increasing demand for spinal fusion devices over the forecast period.

The Global Interventional Oncology Devices Market size was valued at USD 1.92 Billion in 2019 and is expected to reach USD 3.11 Billion by 2027 at a CAGR of 6.6%. The global Interventional Oncology Devices market is forecasted to expand exponentially owing to the rising preference for minimally invasive surgical procedures. The increasing government initiatives to support Interventional Oncology is anticipated to further propel the market growth over the forecasted timeframe.

The global spinal implants and surgery devices market size was valued at USD 10.22 Billion in 2019 and is forecasted to reach USD 14.70 Billion by 2027 at a CAGR of 4.6%. The spinal implants and surgery devices market is observing high demand owing to factors including the rising occurrence of spinal disorders, a rise in the elderly population, growing inclination for less invasive surgery, and growing research activities for developing technologically updated in spinal devices.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:Eric LeeCorporate Sales SpecialistEmergen Research | Web: http://www.emergenresearch.comDirect Line: +1 (604) 757-9756E-mail: [emailprotected]Facebook| LinkedIn| Twitter| Blogs

Read Full Press [emailprotected] https://www.emergenresearch.com/press-release/global-3d-bioprinting-market

SOURCE Emergen Research

Original post:

3D Bioprinting Market Size to Reach USD 2,687.8 Million in 2027 | Increasing Use of 3D Bioprinters in Medical Procedures, Training and Testing Along...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh